Movia launches TheraPal robots for cognitive and social development
Listen to this article
robotic movie this week launched its TheraPal line of digital health aids for autism spectrum disorders and other intellectual or developmental disabilities.
Bristol, Connecticut-based Movia Robotics has launched its TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical assistive aids for use in clinicians’ homes and offices. The robotic aids are designed to be used by parents, therapists and other healthcare professionals for the development and learning of people with neurodevelopmental or intellectual challenges, according to the company.
Movia’s robot-assisted intervention is a user-friendly digital tool that uses Applied Behavior Analysis and other evidence-based methods with gamification techniques to enable children and older adults to practice a wide range of life skills. life and confidence-building activities.
The fully configurable system includes modules for cognitive training, communication training, practice and pedagogical learning. It helps individuals understand and practice basic social skills such as eye contact, confidence building, conversation and other intellectual skills such as reading comprehension, basic math and learning auditory processing. Robot-assisted intervention sends data to healthcare professionals who can adjust professional therapies as needed.
“By using robots that engage and interact with children, we are able to get autistic children to respond more easily,” Movia Robotics founder Timothy Gifford said of the technology. “Robots seem friendlier, less judgmental than human beings; they feel safer, so children are able to explore more, build confidence and have more control while learning skills to help them succeed in their daily lives.
Movia Robotics said its TheraPal product line helps neurodiverse children with an individualized treatment plan. Its TheraPal Progress Tracker is a medical device data system that is used as an assistive tool for home care individuals and clinicians.
“We are focused on demonstrating how robotics can improve the lives of people with autism and other special needs, and the launch of our TheraPal is the first step in our commitment to FDA digital health certification. “, said CEO Jean-Pierre Bolat.
Editor’s note: This article was republished from a sister publication Medical design and outsourcing.